Pub Date : 2019-01-01DOI: 10.14744/DAJPNS.2019.00005
Tugba Gorgulu
Correspondence: Tugba Gorgulu, 1Visit.Asst.Prof., University of Rochester, Department of Psychiatry, 2Dr.Ogr.U., Istinye University, Department of Social Work, Istanbul Turkey Phone: +90 850 283 60 00 E-mail: Tugba_Gorgulu@URMC.Rochester.edu Received: June 11, 2018; Revised: July 05, 2018; Accepted: September 26, 2018 ABSTRACT Objective: Substance use behavior is increasing in Turkey, as is the importance of substance use treatment and rehabilitation programs. Substance users’ compliance and treatment motivation are crucial for the effectiveness of treatment and rehabilitation programs. Accordingly, the purpose of this study is to examine the relationship between psychosocial variables and treatment motivation and to determine the effects of psychosocial variables, self-efficacy, and coping strategies on treatment motivation. Method: The study was conducted among 336 substance users taking part in a Cigarette, Alcohol and Drug Addiction Treatment Program (SAMBA) group program. Results: A significant difference in treatment motivation was found according to the individual’s age, educational status, and income level, duration of substance use and number of substances used, family problems, and psychiatric comorbidity. In addition, the most important predictive variables for treatment motivation are the individual’s income level, the presence of children, family problems, and coping strategies. Conclusion: Cognitive and behavioral studies should be undertaken to strengthen social support mechanisms, to increase the supportive participation of family members, and to develop coping strategies as well as motivational techniques in order to increase the individuals’ compliance and motivation.
{"title":"The effect of self-efficacy and coping strategies on treatment motivation of individuals in the substance addiction group work process","authors":"Tugba Gorgulu","doi":"10.14744/DAJPNS.2019.00005","DOIUrl":"https://doi.org/10.14744/DAJPNS.2019.00005","url":null,"abstract":"Correspondence: Tugba Gorgulu, 1Visit.Asst.Prof., University of Rochester, Department of Psychiatry, 2Dr.Ogr.U., Istinye University, Department of Social Work, Istanbul Turkey Phone: +90 850 283 60 00 E-mail: Tugba_Gorgulu@URMC.Rochester.edu Received: June 11, 2018; Revised: July 05, 2018; Accepted: September 26, 2018 ABSTRACT Objective: Substance use behavior is increasing in Turkey, as is the importance of substance use treatment and rehabilitation programs. Substance users’ compliance and treatment motivation are crucial for the effectiveness of treatment and rehabilitation programs. Accordingly, the purpose of this study is to examine the relationship between psychosocial variables and treatment motivation and to determine the effects of psychosocial variables, self-efficacy, and coping strategies on treatment motivation. Method: The study was conducted among 336 substance users taking part in a Cigarette, Alcohol and Drug Addiction Treatment Program (SAMBA) group program. Results: A significant difference in treatment motivation was found according to the individual’s age, educational status, and income level, duration of substance use and number of substances used, family problems, and psychiatric comorbidity. In addition, the most important predictive variables for treatment motivation are the individual’s income level, the presence of children, family problems, and coping strategies. Conclusion: Cognitive and behavioral studies should be undertaken to strengthen social support mechanisms, to increase the supportive participation of family members, and to develop coping strategies as well as motivational techniques in order to increase the individuals’ compliance and motivation.","PeriodicalId":11480,"journal":{"name":"Dusunen Adam: The Journal of Psychiatry and Neurological Sciences","volume":"48 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80739676","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-01-01DOI: 10.14744/dajpns.2019.00023
A. Polat
{"title":"Quetiapıne-Induced Peripheral Edema: Case Series","authors":"A. Polat","doi":"10.14744/dajpns.2019.00023","DOIUrl":"https://doi.org/10.14744/dajpns.2019.00023","url":null,"abstract":"","PeriodicalId":11480,"journal":{"name":"Dusunen Adam: The Journal of Psychiatry and Neurological Sciences","volume":"47 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74128715","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-01-01DOI: 10.14744/DAJPNS.2019.00001
J. Elhai, J. Levine, B. Hall
{"title":"Problematic smartphone use and mental health problems: current state of research and future directions","authors":"J. Elhai, J. Levine, B. Hall","doi":"10.14744/DAJPNS.2019.00001","DOIUrl":"https://doi.org/10.14744/DAJPNS.2019.00001","url":null,"abstract":"","PeriodicalId":11480,"journal":{"name":"Dusunen Adam: The Journal of Psychiatry and Neurological Sciences","volume":"7 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74998220","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-01-01DOI: 10.14744/dajpns.2019.00051
Nur Seda Gulcu, A. Karayağmurlu
Various factors may contribute to the emergence of Autism Spectrum Disorder (ASD). Genetic factors are particularly prominent in the etiology of ASD, and genetic syndromes may frequently accompany the disorder. Coffin-Siris syndrome is a genetic condition characterized by mental retardation, coarse facial appearance, hirsutism/hypertrichosis or skin with sparse hair, distal phalanx aplasia or hypoplasia, and fifth-finger and nail abnormalities. This genetic syndrome is accompanied by numerous different cardiac, genitourinary, gastrointestinal, ophthalmological, and craniofacial systemic abnormalities. ARID1B gene mutation is thought to be involved both in Coffin-Siris syndrome and in the etiology of autism. Although common genetic factors are involved in the etiologies of both diseases, our review of the literature revealed only one case report demonstrating an association between Coffin-Siris syndrome and ASD. This report describes a male patient aged 2 years and 10 months with ARID1B mutation showing Coffin-Siris syndrome and ASD comorbidity. It may be beneficial for clinicians to remember the coexistence of genetic syndromes in patients diagnosed with ASD and to request consultations from relevant departments for early diagnosis and treatment.
{"title":"ARID1B gene mutation in a patient with Coffin-Siris syndrome and Autism Spectrum Disorder","authors":"Nur Seda Gulcu, A. Karayağmurlu","doi":"10.14744/dajpns.2019.00051","DOIUrl":"https://doi.org/10.14744/dajpns.2019.00051","url":null,"abstract":"Various factors may contribute to the emergence of Autism Spectrum Disorder (ASD). Genetic factors are particularly prominent in the etiology of ASD, and genetic syndromes may frequently accompany the disorder. Coffin-Siris syndrome is a genetic condition characterized by mental retardation, coarse facial appearance, hirsutism/hypertrichosis or skin with sparse hair, distal phalanx aplasia or hypoplasia, and fifth-finger and nail abnormalities. This genetic syndrome is accompanied by numerous different cardiac, genitourinary, gastrointestinal, ophthalmological, and craniofacial systemic abnormalities. ARID1B gene mutation is thought to be involved both in Coffin-Siris syndrome and in the etiology of autism. Although common genetic factors are involved in the etiologies of both diseases, our review of the literature revealed only one case report demonstrating an association between Coffin-Siris syndrome and ASD. This report describes a male patient aged 2 years and 10 months with ARID1B mutation showing Coffin-Siris syndrome and ASD comorbidity. It may be beneficial for clinicians to remember the coexistence of genetic syndromes in patients diagnosed with ASD and to request consultations from relevant departments for early diagnosis and treatment.","PeriodicalId":11480,"journal":{"name":"Dusunen Adam: The Journal of Psychiatry and Neurological Sciences","volume":"98 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74350558","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-01-01DOI: 10.14744/DAJPNS.2019.00018
D. Delibaş, P. Zorlu, Emel Pasa Baskin, E. Bora, Z. Adıbelli, N. Zorlu
How to cite this article: Delibas DH, Kurtgoz Zorlu P, Pasa Baskin E, Bora E, Adibelli ZH, Zorlu N. Is it important to take the co-occurrence of obesity and cigarette smoking into account in brain imaging studies in major depressive disorder? Dusunen Adam The Journal of Psychiatry and Neurological Sciences 2019;32:121-8. Is it important to take the co-occurrence of obesity and cigarette smoking into account in brain imaging studies in major depressive disorder?
Delibas DH, Kurtgoz Zorlu P, Pasa Baskin E, Bora E, Adibelli ZH, Zorlu N.在重度抑郁症的脑成像研究中考虑肥胖和吸烟的共同发生是否重要?Dusunen Adam精神病学和神经科学杂志2019;32:21 1-8。在重度抑郁症的脑成像研究中考虑肥胖和吸烟的共同发生是否重要?
{"title":"Is it importance to take co-occurrence of obesity and cigarette smoking into account in brain imaging studies in major depressive disorder?","authors":"D. Delibaş, P. Zorlu, Emel Pasa Baskin, E. Bora, Z. Adıbelli, N. Zorlu","doi":"10.14744/DAJPNS.2019.00018","DOIUrl":"https://doi.org/10.14744/DAJPNS.2019.00018","url":null,"abstract":"How to cite this article: Delibas DH, Kurtgoz Zorlu P, Pasa Baskin E, Bora E, Adibelli ZH, Zorlu N. Is it important to take the co-occurrence of obesity and cigarette smoking into account in brain imaging studies in major depressive disorder? Dusunen Adam The Journal of Psychiatry and Neurological Sciences 2019;32:121-8. Is it important to take the co-occurrence of obesity and cigarette smoking into account in brain imaging studies in major depressive disorder?","PeriodicalId":11480,"journal":{"name":"Dusunen Adam: The Journal of Psychiatry and Neurological Sciences","volume":"49 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87565734","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-01-01DOI: 10.14744/DAJPNS.2019.00009
Kubra Sozer
While obesity surgery can improve obesity and its complications, it may decrease the absorption of some foods in the stomach. It is known that from the first day after gastric bypass operation, the blood level of B12 start to decrease. However, the change of B12 levels can be measurable after 6 months. B12 deficiency may cause several psychiatric and neurological disorders or aggravate psychiatric symptoms. In this case report, we present a patient who had been in remission before gastric surgery but developed major depression with psychotic features and to describe the course of treatment.
{"title":"Psychotic depression after obesity surgery and recovery with vitamin B12 replacement","authors":"Kubra Sozer","doi":"10.14744/DAJPNS.2019.00009","DOIUrl":"https://doi.org/10.14744/DAJPNS.2019.00009","url":null,"abstract":"While obesity surgery can improve obesity and its complications, it may decrease the absorption of some foods in the stomach. It is known that from the first day after gastric bypass operation, the blood level of B12 start to decrease. However, the change of B12 levels can be measurable after 6 months. B12 deficiency may cause several psychiatric and neurological disorders or aggravate psychiatric symptoms. In this case report, we present a patient who had been in remission before gastric surgery but developed major depression with psychotic features and to describe the course of treatment.","PeriodicalId":11480,"journal":{"name":"Dusunen Adam: The Journal of Psychiatry and Neurological Sciences","volume":"32 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73789319","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-01-01DOI: 10.14744/dajpns.2019.00053
Y. Değirmenci, H. Keçeci
Sodium valproate is a well-known antiepileptic agent with multiple mechanism of action such as sodium channel blockage, gamma-aminobutyric acid activity induction. Despite its’ well-described anxiolytic and mood stabilization effects, its’ mechanism of action on pathological gambling is not clear. However, it has been reported as an effective treatment option on pathological gambling in patients without Parkinson’s disease (PD). We presented a young man with the diagnosis of PD suffering from pathological gambling as an impulse ACCEPTED MANUSCRIPT 2019 control disorder due to anti-pakinsonian drugs, who did not respond to drug adjustments, but showed a complete improvement with sodium valproate, without any worsening in PD symptoms. Key-words: Parkinson’s disease, impulse control disorders, pathological gambling, sodium valproate. BIR PARKINSON HASTASINDA PATOLOJIK KUMAR OYNAMA VE SODYUM VALPROAT CEVABI ÖZET Sodyum valproat, sodyum kanal blokajı, gama-aminobütirik asit aktivitesi indüksiyonu gibi çoklu etki mekanizması olan iyi bilinen bir antiepileptic ajandır. İyi tanımlanmış anksiyolitik ve duygudurum düzenleyici etkisine rağmen, patolojik kumar oynama üzerindeki etki mekanizması açık değildir. Bununla birlikte, Parkinson hastalığı (PH) olmayan hastalardaki patolojik kumar oynama üzerinde etkin bir tedavi seçeneğ olarak bildirilmiştir. Biz PH tanısı almış, anti-parkinson ilaçlara bağlı bir dürtü kontrol bozukluğu olarak patolojik kumar oynamadan yakınan, ilaç ayarlamalarına cevap vermeyen fakat sodium valproat ile; PH semptomlarında herhangi bir kötüleşme olmaksızın tam düzelme gösteren genç bir erkek hastayı sunduk. Anahtar Kelimeler: Parkinson hastalığı, dürtü kontrol bozukluğu, patolojik kumar oynama, sodium valproate. INTRODUCTION Idiopathic Parkinson’ s disease (IPD) is a chronic, neurodegenerative, progressive disorder due to the dysfunction of dopaminergic transmission in basal ganglia, and characterized with cardinal motor symptoms including bradykinesia, rest tremor, rigidity, and postural instability, as well as the non-motor symptoms such as hyposmia, mood disorders, cognitive, autonomic dysfunction, sleep problems, and many others. As the disease progresses, patients are prone to expose dopaminergic therapy induced complications including motor fluctuations, levodopa-induced dyskinesia, and impulse control disorders (ICDs) (1). Impulse control disorders are a number of repetitive and reward-based behaviours, which are reported to occur in a prevalence of 8.1 % and 35 % among patients with PD (2). Hypersexuality, compulsive shopping, binge eating and pathological gambling are known as the major ICDs, however hobbyism, punding, hoarding, and dopamine dysregulation syndrome are also classified in the broad spectrum of ICDs, which are common in patients with PD, in the course of the disease (3). The pathophysiology of ICDs is thought to be associated with the use of antiparkinsonian dopaminergic drugs, affecting the mesocorticolimbic d
{"title":"Pathological Gambling In A Patient With Parkinson’s Disease And Valproate Response","authors":"Y. Değirmenci, H. Keçeci","doi":"10.14744/dajpns.2019.00053","DOIUrl":"https://doi.org/10.14744/dajpns.2019.00053","url":null,"abstract":"Sodium valproate is a well-known antiepileptic agent with multiple mechanism of action such as sodium channel blockage, gamma-aminobutyric acid activity induction. Despite its’ well-described anxiolytic and mood stabilization effects, its’ mechanism of action on pathological gambling is not clear. However, it has been reported as an effective treatment option on pathological gambling in patients without Parkinson’s disease (PD). We presented a young man with the diagnosis of PD suffering from pathological gambling as an impulse ACCEPTED MANUSCRIPT 2019 control disorder due to anti-pakinsonian drugs, who did not respond to drug adjustments, but showed a complete improvement with sodium valproate, without any worsening in PD symptoms. Key-words: Parkinson’s disease, impulse control disorders, pathological gambling, sodium valproate. BIR PARKINSON HASTASINDA PATOLOJIK KUMAR OYNAMA VE SODYUM VALPROAT CEVABI ÖZET Sodyum valproat, sodyum kanal blokajı, gama-aminobütirik asit aktivitesi indüksiyonu gibi çoklu etki mekanizması olan iyi bilinen bir antiepileptic ajandır. İyi tanımlanmış anksiyolitik ve duygudurum düzenleyici etkisine rağmen, patolojik kumar oynama üzerindeki etki mekanizması açık değildir. Bununla birlikte, Parkinson hastalığı (PH) olmayan hastalardaki patolojik kumar oynama üzerinde etkin bir tedavi seçeneğ olarak bildirilmiştir. Biz PH tanısı almış, anti-parkinson ilaçlara bağlı bir dürtü kontrol bozukluğu olarak patolojik kumar oynamadan yakınan, ilaç ayarlamalarına cevap vermeyen fakat sodium valproat ile; PH semptomlarında herhangi bir kötüleşme olmaksızın tam düzelme gösteren genç bir erkek hastayı sunduk. Anahtar Kelimeler: Parkinson hastalığı, dürtü kontrol bozukluğu, patolojik kumar oynama, sodium valproate. INTRODUCTION Idiopathic Parkinson’ s disease (IPD) is a chronic, neurodegenerative, progressive disorder due to the dysfunction of dopaminergic transmission in basal ganglia, and characterized with cardinal motor symptoms including bradykinesia, rest tremor, rigidity, and postural instability, as well as the non-motor symptoms such as hyposmia, mood disorders, cognitive, autonomic dysfunction, sleep problems, and many others. As the disease progresses, patients are prone to expose dopaminergic therapy induced complications including motor fluctuations, levodopa-induced dyskinesia, and impulse control disorders (ICDs) (1). Impulse control disorders are a number of repetitive and reward-based behaviours, which are reported to occur in a prevalence of 8.1 % and 35 % among patients with PD (2). Hypersexuality, compulsive shopping, binge eating and pathological gambling are known as the major ICDs, however hobbyism, punding, hoarding, and dopamine dysregulation syndrome are also classified in the broad spectrum of ICDs, which are common in patients with PD, in the course of the disease (3). The pathophysiology of ICDs is thought to be associated with the use of antiparkinsonian dopaminergic drugs, affecting the mesocorticolimbic d","PeriodicalId":11480,"journal":{"name":"Dusunen Adam: The Journal of Psychiatry and Neurological Sciences","volume":"27 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80322342","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-01-01DOI: 10.14744/dajpns.2019.00047
M. Usta
How to cite this article: Usta MB, Aral A, Sahin B, Bozkurt B, Karabekiroglu K. Examination of neutrophil-, platelet-, and monocyte-lymphocyte ratios in adolescents with bipolar disorder-manic episode and depression. Dusunen Adam The Journal of Psychiatry and Neurological Sciences 2019;32:328-333. Examination of neutrophil, platelet, and monocytelymphocyte ratios in adolescents with bipolar disorder-manic episode and depression
{"title":"Examination of Neutrophil, Platelet, Monocyte-Lymphocyte Ratios in Adolescents with Bipolar Disorder-Manic Episode and Depression","authors":"M. Usta","doi":"10.14744/dajpns.2019.00047","DOIUrl":"https://doi.org/10.14744/dajpns.2019.00047","url":null,"abstract":"How to cite this article: Usta MB, Aral A, Sahin B, Bozkurt B, Karabekiroglu K. Examination of neutrophil-, platelet-, and monocyte-lymphocyte ratios in adolescents with bipolar disorder-manic episode and depression. Dusunen Adam The Journal of Psychiatry and Neurological Sciences 2019;32:328-333. Examination of neutrophil, platelet, and monocytelymphocyte ratios in adolescents with bipolar disorder-manic episode and depression","PeriodicalId":11480,"journal":{"name":"Dusunen Adam: The Journal of Psychiatry and Neurological Sciences","volume":"8 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91532625","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-01-01DOI: 10.14744/dajpns.2019.00019
G. Kaynar
{"title":"Otobiyografik Anılar ve Duygular: Şema Modeli Açısından Bir İnceleme","authors":"G. Kaynar","doi":"10.14744/dajpns.2019.00019","DOIUrl":"https://doi.org/10.14744/dajpns.2019.00019","url":null,"abstract":"","PeriodicalId":11480,"journal":{"name":"Dusunen Adam: The Journal of Psychiatry and Neurological Sciences","volume":"38 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76946684","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-01-01DOI: 10.14744/DAJPNS.2019.00013
C. Evren, V. Karabulut
{"title":"Heightened misuse risk and addictive potential of gabapentinoids: the fate of effective anxiolytics","authors":"C. Evren, V. Karabulut","doi":"10.14744/DAJPNS.2019.00013","DOIUrl":"https://doi.org/10.14744/DAJPNS.2019.00013","url":null,"abstract":"","PeriodicalId":11480,"journal":{"name":"Dusunen Adam: The Journal of Psychiatry and Neurological Sciences","volume":"108 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79390821","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：